Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 11.01B | 11.12B | 11.02B | 9.74B | 8.68B | 8.27B |
Gross Profit | 5.25B | 5.19B | 5.00B | 4.48B | 4.07B | 3.47B |
EBITDA | 1.98B | 1.93B | 1.86B | 1.68B | 1.46B | 1.07B |
Net Income | 1.29B | 1.22B | 1.20B | 1.06B | 880.31M | 589.82M |
Balance Sheet | ||||||
Total Assets | 14.42B | 14.73B | 14.91B | 13.71B | 12.09B | 11.43B |
Cash, Cash Equivalents and Short-Term Investments | 2.89B | 3.21B | 4.08B | 3.79B | 3.60B | 3.46B |
Total Debt | 400.00M | 388.00M | 388.00M | 388.00M | 388.00M | 388.00M |
Total Liabilities | 4.48B | 4.43B | 4.88B | 4.74B | 3.97B | 3.92B |
Stockholders Equity | 9.94B | 10.30B | 10.02B | 8.97B | 8.12B | 7.51B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 621.46M | 702.09M | 629.76M | 576.81M | 1.06B |
Operating Cash Flow | 0.00 | 1.02B | 1.14B | 899.76M | 757.09M | 1.14B |
Investing Cash Flow | 0.00 | -815.18M | -465.49M | -429.69M | -294.12M | -80.97M |
Financing Cash Flow | 0.00 | -985.87M | -407.12M | -330.74M | -320.04M | -327.22M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥12.07B | 9.48 | 2.26% | 2.63% | 268.28% | ||
75 Outperform | ¥11.22B | 9.14 | 3.21% | 0.94% | 3.26% | ||
73 Outperform | ¥12.56B | 9.95 | 3.72% | -6.96% | -1.72% | ||
67 Neutral | €8.08B | 19.96 | 6.46% | 2.73% | 1.89% | -38.57% | |
58 Neutral | ¥11.22B | ― | 3.42% | -1.17% | 63.91% | ||
57 Neutral | ¥12.00B | 15.57 | 2.04% | 25.48% | ― |